A DNA Aptamer Targeting Galectin-1 as a Novel Immunotherapeutic Strategy for Lung Cancer
Galectin-1 (Gal-1) is a pleiotropic homodimeric β-galactoside-binding protein with a single carbohydrate recognition domain. It has been implicated in several biological processes that are important during tumor progression. Several lines of evidence have indicated that Gal-1 is involved in cancer i...
Saved in:
Main Authors: | Yao-Tsung Tsai (Author), Chen-Hsien Liang (Author), Jin-Hsuan Yu (Author), Kuan-Chih Huang (Author), Chia-Hao Tung (Author), Jia-En Wu (Author), Yi-Ying Wu (Author), Chih-Hsien Chang (Author), Tse-Ming Hong (Author), Yuh-Ling Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2
by: Yi-Ying Wu, et al.
Published: (2022) -
Generation of DNA-aptamers targeting galectin-7 for the identification of cholesteatoma residue
by: Shuang Liu, et al.
Published: (2022) -
Galectins and cutaneous immunity
by: Huan-Yuan Chen, et al.
Published: (2012) -
Topical DNA aptamer therapeutics for the skin
by: Simon C.C. Shiu, et al.
Published: (2024) -
Logic Gates Based on DNA Aptamers
by: Mariia Andrianova, et al.
Published: (2020)